A pharmacological approach to the mode of digitalis action.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001692:Biological Transport; D002301:Cardiac Glycosides / Q000008:administration & dosage / Q000494:pharmacology*; D002395:Catecholamines / Q000494:pharmacology; D002628:Chemoreceptor Cells; D004071:Digitalis Glycosides / Q000494:pharmacology*; D004074:Digitoxin / Q000494:pharmacology; D004077:Digoxin / Q000494:pharmacology; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006633:Histamine Antagonists; D006801:Humans; D006863:Hydrogen-Ion Concentration; D009130:Muscle, Smooth / Q000187:drug effects; D009451:Neuroeffector Junction / Q000187:drug effects; D010042:Ouabain / Q000494:pharmacology; D051381:Rats; D013696:Temperature
D002301:Cardiac Glycosides; D002395:Catecholamines; D004071:Digitalis Glycosides; D006633:Histamine Antagonists; D010042:Ouabain; D004077:Digoxin; D000255:Adenosine Triphosphate; D004074:Digitoxin; D000109:Acetylcholine; D004837:Epinephrine